Respiratory Disorder

Trusted pharma products in Respiratory Disorder

DALTEPARIN

Strength: 10000 IU

Form: Injection

Reference Brands:

View More Get Enquiry
DALTEPARIN

Strength: 2500IU

Form: Injection

Reference Brands:

View More Get Enquiry
DALTEPARIN

Strength: 5000IU

Form: 5000

Reference Brands:

View More Get Enquiry
Dextromethorphan Hbr + Bromhexine HCl + Guaiphenesin + Phenylepherine HCl + CPM Tablet

Strength: 15mg + 8mg + 100mg + 5mg + 4mg

Form: Tablets

Reference Brands:

View More Get Enquiry
Diethyl Carbamazine Citrate + Cetirizine HCl Tablet

Strength: 150mg + 5mg

Form: Tablets

Reference Brands:

View More Get Enquiry
Doxofylline

Strength: Tab: 200 mg, 400 mg; Syrup: 100 mg/5 mL

Form: Tablet & Syrup

Reference Brands: Doxolin®, Respiridox®(India)

View More Get Enquiry
Doxofylline Tablet

Strength: 400mg

Form: Tablets

Reference Brands:

View More Get Enquiry
Ethofylline & Theophylline

Strength: 84.7 mg Ethofylline + 25.3 mg Theophylline

Form: Injection

Reference Brands: Deriphyllin® , Derin®

View More Get Enquiry
Ethofylline & Theophylline Injection

Strength: 84.7mg + 25.3mg/ml

Form: Injection

Reference Brands:

View More Get Enquiry
Fluticasone furoate + Vilanterol

Strength: 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol

Form: Powder For Inhalation(DPI/MDI)

Reference Brands: Breo Ellipta®(US), Relvar Ellipta® (EU)

View More Get Enquiry
Fluticasone Propionate

Strength: 0.5 mg/2 mL ampoules, 1 mg/2 mL ampoules

Form: Inhalation suspension for use with nebulizers

Reference Brands: Flixotide Nebules(EU)

View More Get Enquiry
Formoterol Fumarate And Budesonide

Strength: DPI: 100 mcg Budesonide / 6 mcg Formoterol, ; MDI: 80 mcg Budesonide / 4.5 mcg Formoterol Fumarate, 160 mcg Budesonide / 4.5 mcg Formoterol Fumarate

Form: Powder For Inhalation(DPI/MDI)

Reference Brands: Symbicort®(US); Symbicort® Turbohaler®, DuoResp® Spiromax®(EU - various strengths available)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.